ArticleApplied biochemistry and biotechnology2025
A Novel Esterase from Burkholderia sp. YD106 Capable of Hydrolysis of Methyl (R, S)-N-(2, 6-Dimethylphenyl) Alaninate, and Its Mutation for Improving Enantioselectivity.
Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Methyl (R, S)-2, 6-dimethylphenylaminopropionate ((R, S)-1) is an intermediate in the production of the agricultural fungicide (R, S)-metalaxyl. (R, S)-1 can be hydrolyzed enantioselectively by some hydrolases to produce (R)-1, which was used for the production of (R)-metalaxyl. In this work, a strain Burkholderia sp. YD106 that could hydrolyze (R, S)-1 was screened from the activated sludge, but it had almost no enantioselectivity. The intracellular active esterase WZest was successfully heterologously expressed in the recombinant E. coli BL21 (DE3)-pET-28a ( +)-GE04845. Using the recombinant strain as the parent strain, the mutants were constructed by a site-directed mutation. Among all 33 mutants, seven had altered enantioselectivity, of which four mutants were (R)-enantioselective and three were (S)-enantioselective. The mutant WZest-W23T had the highest (R)-enantioselectivity. When it catalyzed the hydrolysis of (R, S)-1 at 44.6% substrate conversion, e.e.
Indexed as
Identifiers
40531301What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.